6-Isothiocyanato-Fluorescein, 10g

5-Iodo-2-nitrobenzoic acid, 95.0%, 100mg

2-(Piperidin-2-yl)pyridine dihydrochloride, 95.0%, 1g

[5-(2-fluorophenyl)isoxazol-3-yl]methanol, 95.0%, 500mg

N-Allyl-N-tert-butylamine, 98.0%, 1g

Ethyl-5-oxooxepane-4-carboxylate, 95.0%, 5g

5-(chloromethyl)-3-(2-methoxyethyl)-1,2,4-oxadiazole, 95.0%, 5g

Objectif à contraste de phase Plan PLPH S100x/1,25

2-[(4-Acetylpiperazin-1-yl)carbonyl]benzoic acid, 95.0%, 250mg

(4-((2,4-Dichlorobenzyl)oxy)phenyl)boronic acid, 95.0%, 1g

3-Methylbenzo[d]isoxazole-5-carbonitrile, 95.0%, 500mg

2-Amino-6-chlorobenzothiazole>98.0%(HPLC)(T)25g

2,5-dibromo-4-nitropyridin-1-ium-1-olate, 1g